Drugs.com - Pharma Industry News

Many With Overweight, Obesity Discontinue GLP-1 Receptor Agonists Within One Year

FRIDAY, Jan. 14, 2025 -- Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those without type 2 diabetes, according to a study...

Feb 15, 2025 - 00:17
 0
Many With Overweight, Obesity Discontinue GLP-1 Receptor Agonists Within One Year
FRIDAY, Jan. 14, 2025 -- Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those without type 2 diabetes, according to a study...
Read More

Tags:

Previous Article

Another MAGA Judge Makes Shocking Legal Argument Hoping To Catch The Attention O...

Next Article

Seroprevalence of HPAI A(H5) Identified in Bovine Veterinary Practitioners

Related Posts

Increase in Mortality Associated With Menthol Cigarette Use

Increase in Mortality Associated With Menthol Cigarette...

Feb 25, 2025  0

Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors

Depression Risk Lower With GLP-1 Receptor Agonists Vers...

Feb 25, 2025  0

Eating Behaviors, Certain Foods Linked to Pelvic Floor Disorders

Eating Behaviors, Certain Foods Linked to Pelvic Floor ...

Feb 26, 2025  0